Alliance Pharma reports mixed results in 2020

21 January 2021 - Deborah Wilkes

Premium

Alliance Pharma said its Consumer Healthcare business had “performed well given the market backdrop” in 2020, with sales up by 1%. By contrast, the UK-based company’s Prescription Medicines business reported sales down by 14% due to the COVID-19 pandemic.

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: